MLchartDataset catalogue

Tibsovo

Term · Oncology and biomedicine · MLC-T-ONC-008708

A drug used alone or with other drugs to treat adults with certain types of acute myeloid leukemia, cholangiocarcinoma (a type of bile duct cancer), or myelodysplastic syndromes that have a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Tibsovo blocks the protein made by the mutated IDH1 gene, which may help keep cancer cells from growing. It is a type of enzyme inhibitor and a type of targeted therapy. Also called ivosidenib.

Table 1. Record
IdentifierMLC-T-ONC-008708
FieldOncology and biomedicine
Synonymsivosidenib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008708",
  "term": "Tibsovo",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat adults with certain types of acute myeloid leukemia, cholangiocarcinoma (a type of bile duct cancer), or myelodysplastic syndromes that have a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Tibsovo blocks the protein made by the mutated IDH1 gene, which may help keep cancer cells from growing. It is a type of enzyme inhibitor and a type of targeted therapy. Also called ivosidenib.",
  "synonyms": [
    "ivosidenib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tibsovo/"
}

Record 16,357 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.